Tectonic Begin Period Cash Flow vs Other Cashflows From Financing Activities Analysis

TECX Stock

50.56 3.00 6.31%

Tectonic Therapeutic, financial indicator trend analysis is much more than just breaking down Tectonic Therapeutic, prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tectonic Therapeutic, is a good investment. Please check the relationship between Tectonic Therapeutic, Begin Period Cash Flow and its Other Cashflows From Financing Activities accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tectonic Therapeutic,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Tectonic Stock please use our How to Invest in Tectonic Therapeutic, guide.

Begin Period Cash Flow vs Other Cashflows From Financing Activities

Begin Period Cash Flow vs Other Cashflows From Financing Activities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tectonic Therapeutic, Begin Period Cash Flow account and Other Cashflows From Financing Activities. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Tectonic Therapeutic,'s Begin Period Cash Flow and Other Cashflows From Financing Activities is -0.36. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Other Cashflows From Financing Activities in the same time period over historical financial statements of Tectonic Therapeutic,, assuming nothing else is changed. The correlation between historical values of Tectonic Therapeutic,'s Begin Period Cash Flow and Other Cashflows From Financing Activities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Tectonic Therapeutic, are associated (or correlated) with its Other Cashflows From Financing Activities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Cashflows From Financing Activities has no effect on the direction of Begin Period Cash Flow i.e., Tectonic Therapeutic,'s Begin Period Cash Flow and Other Cashflows From Financing Activities go up and down completely randomly.

Correlation Coefficient

-0.36

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Other Cashflows From Financing Activities

Most indicators from Tectonic Therapeutic,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tectonic Therapeutic, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tectonic Therapeutic,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Tectonic Stock please use our How to Invest in Tectonic Therapeutic, guide.Selling General Administrative is likely to drop to about 7.1 M in 2024. Issuance Of Capital Stock is likely to drop to about 41.7 M in 2024

	2021	2022	2023	2024 (projected)
Total Operating Expenses	117.4M	101.3M	44.6M	76.5M
Cost Of Revenue	1.4M	4.2M	617K	586.2K

Total Operating Expenses Cost Of Revenue

Tectonic Therapeutic, fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Current Deferred Revenue	Capital Lease Obligations	Net Invested Capital	Property Plant And Equipment Gross
Total Assets		0.75	0.8	1.0	0.49	-0.98	0.99	0.99	0.97	0.68	-0.22	-0.72	0.97	0.95	-0.95	-0.62	0.96	0.72	0.06	0.97	0.65	0.65	0.95	-0.95	0.96	-0.95
Other Current Liab	0.75		0.47	0.76	0.4	-0.78	0.79	0.76	0.76	0.53	-0.18	-0.65	0.76	0.56	-0.87	-0.61	0.9	0.23	-0.1	0.76	0.58	0.63	0.55	-0.56	0.56	-0.57
Total Current Liabilities	0.8	0.47		0.74	0.83	-0.83	0.74	0.81	0.85	0.91	-0.67	-0.87	0.85	0.89	-0.68	-0.04	0.69	0.39	0.61	0.86	0.73	0.84	0.84	-0.9	0.85	-0.91
Total Stockholder Equity	1.0	0.76	0.74		0.42	-0.97	0.99	0.98	0.95	0.62	-0.14	-0.67	0.95	0.92	-0.96	-0.69	0.97	0.75	-0.02	0.95	0.61	0.6	0.94	-0.92	0.94	-0.92
Property Plant And Equipment Net	0.49	0.4	0.83	0.42		-0.62	0.5	0.57	0.66	0.97	-0.96	-0.94	0.66	0.63	-0.5	0.33	0.44	0.0	0.87	0.67	0.89	0.96	0.56	-0.54	0.57	-0.56
Net Debt	-0.98	-0.78	-0.83	-0.97	-0.62		-0.99	-1.0	-1.0	-0.79	0.38	0.83	-1.0	-0.95	0.97	0.51	-0.95	-0.64	-0.2	-1.0	-0.78	-0.78	-0.95	0.91	-0.95	0.92
Retained Earnings	0.99	0.79	0.74	0.99	0.5	-0.99		0.99	0.98	0.69	-0.24	-0.74	0.98	0.93	-0.99	-0.63	0.97	0.72	0.06	0.98	0.71	0.68	0.94	-0.89	0.94	-0.89
Accounts Payable	0.99	0.76	0.81	0.98	0.57	-1.0	0.99		0.99	0.75	-0.31	-0.79	0.99	0.96	-0.97	-0.56	0.95	0.7	0.14	0.99	0.74	0.72	0.96	-0.92	0.96	-0.92
Cash	0.97	0.76	0.85	0.95	0.66	-1.0	0.98	0.99		0.82	-0.42	-0.86	1.0	0.96	-0.96	-0.47	0.94	0.62	0.25	1.0	0.81	0.8	0.95	-0.91	0.95	-0.92
Non Current Assets Total	0.68	0.53	0.91	0.62	0.97	-0.79	0.69	0.75	0.82		-0.86	-0.99	0.82	0.79	-0.68	0.11	0.62	0.21	0.75	0.83	0.93	0.98	0.74	-0.71	0.74	-0.72
Non Currrent Assets Other	-0.22	-0.18	-0.67	-0.14	-0.96	0.38	-0.24	-0.31	-0.42	-0.86		0.82	-0.42	-0.41	0.24	-0.58	-0.17	0.22	-0.96	-0.44	-0.78	-0.85	-0.32	0.3	-0.33	0.33
Other Assets	-0.72	-0.65	-0.87	-0.67	-0.94	0.83	-0.74	-0.79	-0.86	-0.99	0.82		-0.86	-0.79	0.75	-0.01	-0.7	-0.21	-0.66	-0.86	-0.95	-0.99	-0.74	0.7	-0.74	0.72
Cash And Short Term Investments	0.97	0.76	0.85	0.95	0.66	-1.0	0.98	0.99	1.0	0.82	-0.42	-0.86		0.96	-0.96	-0.47	0.94	0.62	0.25	1.0	0.81	0.8	0.95	-0.91	0.95	-0.92
Net Receivables	0.95	0.56	0.89	0.92	0.63	-0.95	0.93	0.96	0.96	0.79	-0.41	-0.79	0.96		-0.87	-0.39	0.84	0.74	0.31	0.96	0.74	0.72	1.0	-0.95	1.0	-0.95
Common Stock Shares Outstanding	-0.95	-0.87	-0.68	-0.96	-0.5	0.97	-0.99	-0.97	-0.96	-0.68	0.24	0.75	-0.96	-0.87		0.65	-0.98	-0.63	-0.02	-0.96	-0.73	-0.7	-0.88	0.82	-0.88	0.82
Non Current Liabilities Total	-0.62	-0.61	-0.04	-0.69	0.33	0.51	-0.63	-0.56	-0.47	0.11	-0.58	-0.01	-0.47	-0.39	0.65		-0.7	-0.66	0.74	-0.46	0.01	0.08	-0.46	0.44	-0.46	0.42
Other Current Assets	0.96	0.9	0.69	0.97	0.44	-0.95	0.97	0.95	0.94	0.62	-0.17	-0.7	0.94	0.84	-0.98	-0.7		0.59	-0.05	0.93	0.63	0.65	0.85	-0.85	0.85	-0.85
Other Stockholder Equity	0.72	0.23	0.39	0.75	0.0	-0.64	0.72	0.7	0.62	0.21	0.22	-0.21	0.62	0.74	-0.63	-0.66	0.59		-0.23	0.62	0.28	0.11	0.8	-0.68	0.79	-0.66
Total Liab	0.06	-0.1	0.61	-0.02	0.87	-0.2	0.06	0.14	0.25	0.75	-0.96	-0.66	0.25	0.31	-0.02	0.74	-0.05	-0.23		0.27	0.62	0.7	0.23	-0.22	0.23	-0.24
Total Current Assets	0.97	0.76	0.86	0.95	0.67	-1.0	0.98	0.99	1.0	0.83	-0.44	-0.86	1.0	0.96	-0.96	-0.46	0.93	0.62	0.27		0.81	0.81	0.95	-0.91	0.95	-0.92
Common Stock	0.65	0.58	0.73	0.61	0.89	-0.78	0.71	0.74	0.81	0.93	-0.78	-0.95	0.81	0.74	-0.73	0.01	0.63	0.28	0.62	0.81		0.94	0.7	-0.57	0.71	-0.59
Short Long Term Debt Total	0.65	0.63	0.84	0.6	0.96	-0.78	0.68	0.72	0.8	0.98	-0.85	-0.99	0.8	0.72	-0.7	0.08	0.65	0.11	0.7	0.81	0.94		0.66	-0.64	0.67	-0.66
Current Deferred Revenue	0.95	0.55	0.84	0.94	0.56	-0.95	0.94	0.96	0.95	0.74	-0.32	-0.74	0.95	1.0	-0.88	-0.46	0.85	0.8	0.23	0.95	0.7	0.66		-0.95	1.0	-0.95
Capital Lease Obligations	-0.95	-0.56	-0.9	-0.92	-0.54	0.91	-0.89	-0.92	-0.91	-0.71	0.3	0.7	-0.91	-0.95	0.82	0.44	-0.85	-0.68	-0.22	-0.91	-0.57	-0.64	-0.95		-0.95	1.0
Net Invested Capital	0.96	0.56	0.85	0.94	0.57	-0.95	0.94	0.96	0.95	0.74	-0.33	-0.74	0.95	1.0	-0.88	-0.46	0.85	0.79	0.23	0.95	0.71	0.67	1.0	-0.95		-0.95
Property Plant And Equipment Gross	-0.95	-0.57	-0.91	-0.92	-0.56	0.92	-0.89	-0.92	-0.92	-0.72	0.33	0.72	-0.92	-0.95	0.82	0.42	-0.85	-0.66	-0.24	-0.92	-0.59	-0.66	-0.95	1.0	-0.95

Click cells to compare fundamentals

Tectonic Therapeutic, Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Tectonic Stock Analysis

When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Tectonic Begin Period Cash Flow vs Other Cashflows From Financing Activities Analysis

Begin Period Cash Flow vs Other Cashflows From Financing Activities

Begin Period Cash Flow vs Other Cashflows From Financing Activities Correlation Analysis

Correlation Coefficient

Begin Period Cash Flow

Other Cashflows From Financing Activities

Tectonic Therapeutic, fundamental ratios Correlations

Tectonic Therapeutic, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Tectonic Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Current Deferred Revenue	+ 1.0	Net Receivables
Net Invested Capital	+ 1.0	Net Receivables

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Accounts Payable	- 1.0	Net Debt
Short Long Term Debt Total	- 0.99	Other Assets
Other Assets	- 0.99	Non Current Assets Total